Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers

被引：0
|
作者：
Duijkers, IJM
Klipping, C
Willemsen, WNP
Krone, D
Schneider, E
Niebch, G
Romeis, P
Hermann, R
机构：
[1] Dinox Med Invest, Nijmegen, Netherlands
[2] Univ Nijmegen Hosp, Dept Obstet & Gynaecol, NL-6500 HB Nijmegen, Netherlands
[3] ASTA Med AG, Corp Res, Dept Biochem, Frankfurt, Germany
[4] ASTA Med AG, Corp Res, Dept Clin Pharmacol, Frankfurt, Germany
来源：
HUMAN REPRODUCTION | 1998年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O239
引用
收藏
页码：123 / 124
页数：2
相关论文
共 50 条
  • [1] Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers
    Duijkers, IJM
    Klipping, C
    Willemsen, WNP
    Krone, D
    Schneider, E
    Niebch, G
    Hermann, R
    HUMAN REPRODUCTION, 1998, 13 (09) : 2392 - 2398
  • [2] Single and multiple dose pharmacokinetics of the LH-RH-antagonist cetrorelix in healthy female volunteers
    Ochs, D
    Romeis, P
    Klipping, C
    Schneider, E
    Hermann, R
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 469 - 469
  • [3] Human ovarian steroid secretion in vivo: effects of gonadotrophin-releasing hormone agonist versus antagonist (cetrorelix)
    Garcia-Velasco, J. A.
    Isaza, V.
    Vidal, C.
    Landazabal, A.
    Remohi, J.
    Simon, C.
    Pellicer, A.
    HUMAN REPRODUCTION, 2001, 16 : 15 - 16
  • [4] Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix)
    Albano, C
    Smitz, J
    Camus, M
    RiethmullerWinzen, H
    SiebertWeigel, M
    Diedrich, K
    VanSteirteghem, AC
    Devroey, P
    HUMAN REPRODUCTION, 1996, 11 (10) : 2114 - 2118
  • [5] Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles
    Ubaldi, F
    Albano, C
    Peukert, M
    RiethmullerWinzen, H
    Camus, M
    Smitz, J
    VanSteirteghem, A
    Devroey, P
    HUMAN REPRODUCTION, 1996, 11 (07) : 1405 - 1407
  • [6] INTERMITTENT ANDROGEN DEPRIVATION WITH THE GONADOTROPHIN-RELEASING HORMONE ANTAGONIST DEGARELIX
    Crawford, David
    Shore, Neal
    Higano, Celestia
    Neijber, Anders
    Yankov, Vladimir
    JOURNAL OF UROLOGY, 2014, 191 (04): : E766 - E766
  • [7] Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders
    Xia, Min
    Zheng, Jie
    BMC PREGNANCY AND CHILDBIRTH, 2021, 21 (01)
  • [8] Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders
    Min Xia
    Jie Zheng
    BMC Pregnancy and Childbirth, 21
  • [9] Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer
    Mongiat-Artus, P
    Teillac, P
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (10) : 2171 - 2179
  • [10] A single and multiple postprandial dose study investigating the pharmacokinetics and pharmacodynamics of edoxaban in healthy Chinese volunteers
    Chen, Xia
    Liu, Dongyang
    Wu, Yiwen
    Liu, Yang
    Song, Hanlin
    Jiang, Ji
    Hu, Pei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (03) : 256 - 263
12345